Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Combination of AVE-1642 and other agents increases activity in hepatocellular carcinoma cells

Sep. 19, 2008

Phase III advanced melanoma study of Genasense cleared to continue

Sep. 19, 2008

S*BIO initiates U.S. phase I trials of oral JAK2 inhibitor SB-1518

Sep. 18, 2008

Davanat data filed for registration in late-stage colorectal cancer

Sep. 18, 2008

Clinical results of PANVAC-VF in metastatic breast cancer reported

Sep. 18, 2008

Compugen discovers peptide drug candidate for treatment of solid tumors

Sep. 18, 2008

Temoporfin improves tumoricidal depth in photodynamic therapy for bile duct cancer

Sep. 18, 2008

Threshold begins phase I/II study for TH-302 in patients with soft tissue sarcoma

Sep. 18, 2008

Abbott identifies novel Tie-2 inhibitors active against cancer in preclinical studies

Sep. 18, 2008

Positive results in aromatase-resistant breast cancer with combined sorafenib/anastrozole therapy

Sep. 17, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...